LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LONDON WALLET
  • Home
  • Investing
  • Business Finance
  • Markets
  • Industries
  • Opinion
  • UK
  • Real Estate
  • Crypto
No Result
View All Result
LondonWallet
No Result
View All Result

Stocks making the biggest moves midday: General Motors, Novo Nordisk, Kenvue, CrowdStrike and more

Garry Wills by Garry Wills
March 5, 2025
in Business Finance
Stocks making the biggest moves midday: General Motors, Novo Nordisk, Kenvue, CrowdStrike and more
74
SHARES
1.2k
VIEWS
Share on FacebookShare on Twitter


Check out the companies making headlines in midday trading: Box — Shares declined more than 3% after the cloud storage company’s top-line guidance fell short of estimates. Box sees first-quarter revenue coming in between $274 million and $275 million, while analysts polled by LSEG expected $279.5 million. Box’s fourth-quarter revenue of $280 million exceeded Wall Street’s consensus of $279 million. AeroVironment — Shares fell 5% after the defense contractor provided weak full-year guidance. AeroVironment expects adjusted earnings for the period to come in between $2.92 and $3.13 per share on revenue of $780 million to $795 million. Analysts surveyed by LSEG were looking for $3.45 per share and $821 million in revenue. Earnings and revenue for the fiscal third quarter also missed expectations. Kenvue — Shares dropped about 1% after Kenvue settled its proxy fight with activist Starboard Value, adding three new directors to its board. Starboard took a significant stake in Kenvue, formerly the consumer health-care division under Johnson & Johnson, and expressed disappointment in its stock performance and management. CrowdStrike — Shares tumbled 7% after the cybersecurity firm guided for first-quarter revenue and operating income numbers that were below expectations. However, CrowdStrike expects its full-year revenue to come in the range of about $4.74 billion to $4.81 billion, which encompasses the $4.77 billion consensus analysts had penciled in, according to FactSet. Abercrombie & Fitch — The apparel retailer tumbled more than 11% after offering a disappointing sales forecast and saying demand for apparel was weak in February. The company, which also owns the Hollister and Gilly Hicks brands, expects 2025 sales growth of between 3% and 5%, which is below the 6.8% consensus from LSEG. For the fiscal first quarter, the retailer expects to earn between $1.25 and $1.45 per share, compared with an analyst estimate of $1.97 per share. Automakers — Shares of General Motors , Ford and Stellantis climbed higher after Bloomberg News reported that the Trump administration may delay auto tariffs for one month. General Motors and Ford shares gained 5% and 4%, respectively, while Stellantis jumped nearly 8%. Dollar Tree — Shares of the discount chain rose nearly 2% after Dollar Tree announced Stewart Glendinning as the company’s next chief financial officer beginning March 30. Novo Nordisk — Novo Nordisk advanced 4% after it announced plans to sell its weight loss drug Wegovy for less than half its usual price through a new direct-to-consumer online pharmacy . Moderna — The biotech stock rallied 7% after CEO Stephane Bancel disclosed he bought around 160,000 shares, or $5 million worth of stock on March 3. The Campbell’s Company — The canned foods company fell 3% after cutting its full-year guidance below analysts’ estimates. Fiscal second-quarter revenue also came in lower than expected. The company cited weakness in its snacking segment. Foot Locker — Shares popped more than 5% after the shoe retailer reported an earnings beat and stronger-than-expected same-store sales in the fourth quarter. — CNBC’s Sean Conlon, Pia Singh, Lisa Kailai Han and Christina Cheddar-Berk contributed reporting.



Source link

You might also like

‘The tide went out’: How a string of bad loans has bank investors hunting for hidden risks

Stocks making the biggest moves midday: Oracle, AST SpaceMobile, Revolution Medicines and more

Gold’s record run leads to latest market-moving tweak to the classic 60/40 investing portfolio

Share30Tweet19
Previous Post

It’s a great time to buy defense stocks as DOGE cuts fears are overblown, says Citi

Next Post

XRP/ETH pair targets 160% rally according to bull market cycle history

Garry Wills

Garry Wills

Recommended For You

‘The tide went out’: How a string of bad loans has bank investors hunting for hidden risks
Business Finance

‘The tide went out’: How a string of bad loans has bank investors hunting for hidden risks

October 17, 2025
Stocks making the biggest moves midday: Oracle, AST SpaceMobile, Revolution Medicines and more
Business Finance

Stocks making the biggest moves midday: Oracle, AST SpaceMobile, Revolution Medicines and more

October 17, 2025
Gold’s record run leads to latest market-moving tweak to the classic 60/40 investing portfolio
Business Finance

Gold’s record run leads to latest market-moving tweak to the classic 60/40 investing portfolio

October 17, 2025
Moody’s says the banking system, private credit markets are sound despite worries over bad loans
Business Finance

Moody’s says the banking system, private credit markets are sound despite worries over bad loans

October 17, 2025
Next Post
XRP/ETH pair targets 160% rally according to bull market cycle history

XRP/ETH pair targets 160% rally according to bull market cycle history

Related News

Former Kraken execs acquire real state firm Janover, disclose SOL treasury plans

Former Kraken execs acquire real state firm Janover, disclose SOL treasury plans

April 7, 2025
Unveiling forex: Navigating the realm of currency pairs

Unveiling forex: Navigating the realm of currency pairs

November 23, 2023
Aster leads perp DEX surge to B daily trading volume

Aster leads perp DEX surge to $70B daily trading volume

September 25, 2025

Browse by Category

  • Business Finance
  • Crypto
  • Industries
  • Investing
  • Markets
  • Opinion
  • Real Estate
  • UK

London Wallet

Read latest news about finance, business and investing

  • Contact
  • Privacy Policy
  • Terms & Conditions

© 2025 London Wallet - All Rights Reserved!

No Result
View All Result
  • Checkout
  • Contact
  • Home
  • Login/Register
  • My account
  • Privacy Policy
  • Terms and Conditions

© 2025 London Wallet - All Rights Reserved!

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?